Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.
This report contains market size and forecasts of Genital Herpes Treatment Drugs in Global, including the following market information:
Global Genital Herpes Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genital Herpes Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genital Herpes Treatment Drugs include AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc. and Teva Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genital Herpes Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genital Herpes Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Acyclovir
Famciclovir
Valacyclovir
Global Genital Herpes Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Genital Herpes Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Genital Herpes Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genital Herpes Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genital Herpes Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.